The global Atherectomy Devices Market by Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices), by Application (Cardiovascular, Neurovascular, and Peripheral Vascular), by End User (Hospitals, Ambulatory Surgical Centers, and Medical Institutes) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 504.5 million in 2016 and is projected to exhibit a CAGR of 6.2% over the forecast period (2017 – 2025).
Frequent approval of innovative atherectomy devices by major regulatory bodies in key regions is expected to be major driving factor for growth of the atherectomy devices Market. In 2015, Spectranetics Corporation received FDA approval for Turbo-Power Laser Atherectomy Catheter, which indicated atherectomy device for treatment of in-stent restenosis. In 2017, Avinger, Inc. received Conformité Européenne (CE) marking approval for next generation Pantheris Lumivascular atherectomy system. In 2017, Ra Medical Systems launched DABRA Atherectomy System in Northern Europe. In 2015, Medtronic Plc. launched its HawkOne directional atherectomy system for the treatment of peripheral arterial disease. Multiple approval and then launch of these innovative devices is expected to support the growth of global atherectomy devices Market.
Browse 36 Market Data Tables and 40 Figures spread through 186 Pages and in-depth TOC on Vascular Closure Device by Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices), By Application (Cardiovascular, Neurovascular and Peripheral Vascular), By End User (Hospitals, Ambulatory Surgical Centers, and Medical Institutes) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025.
To know the latest trends and insights prevalent in the atherectomy devices market, click the link below:
Furthermore, the market has witnessed multiple mergers and acquisitions is recent years, which has helped leading companies to its atherectomy device portfolio and hence, strengthen position in atherectomy device market. In 2014, Boston Scientific Corporation acquired Bayer AG interventional business. This acquisition includes AngioJet Thrombectomy System, Fetch 2 Aspiration Catheter, and JetStream Atherectomy System. The JetStream Atherectomy System is used to remove plaque and thrombus from diseased arteries. In 2014, Medtronic plc acquired Covidien plc in order to expand portfolio of atherectomy device. After this acquisition, Medtronic plc became the sole owner of leading atherectomy devices such as HawkOne, TurboHawk, and may others.
Key Takeaways of the Atherectomy Devices Market:
Major players operating in the atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik